Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Internal Medicine Journal|April 28, 2006
Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosusA B Lee, T Godfrey, K G Rowley, et al.Diabetologia|September 7, 2006
Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetesY Yu, S R Thorpe, A J Jenkins, et al.Journal of the South Carolina Medical Association (1975)|December 9, 1998
Diabetes research in South Carolina: past, present, and futureS M Willi, D O'Rear, W T Garvey, et al.Lupus|October 11, 2018
Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosusF B Vincent, R Kandane-Rathnayake, A Y Hoi, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2007
Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetesA J Jenkins, S X Zhang, K G Rowley, et al.Diabetologia|November 6, 2010
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyT M E Davis, R Ting, J D Best, et al.BJOG : an International Journal of Obstetrics and Gynaecology|August 21, 2012
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetesY Yu, K F Hanssen, V Kalyanaraman, et al.Diabetologia|November 6, 2008
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic womenY Yu, A J Jenkins, A J Nankervis, et al.Pageof 8